Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine plus lidocaine infusion versus placebo for myocardial injury reduction after cardiac surgery
TCTR20260815005Phase 4Not yet recruiting
- Sponsor
- Assist Prof. Naruenart Lomarat
- Start
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dexmedetomidine, lidocaine in Myocardial injury, sponsored by Assist Prof. Naruenart Lomarat. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
dexmedetomidinelidocaine
03
Conditions
Myocardial injury
Beyond the preview
Go deeper on TCTR20260815005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260815005.